Concepedia

Sayantani Roy

SR

Statistics

Publications

8

Citations

244

H-Index

8

Active since

2007

Affiliations

Max Planck Institute of Molecular Physiology(Current)

Indian Institute of Chemical Technology

Indian Institute of Technology Kharagpur

TU Dortmund University

Sayantani Roy is an author at Max Planck Institute of Molecular Physiology specializing in cancer pharmacology, drug discovery, and molecular biology.

ORCID

Publications per year

2007–2021

8

Publications

8

Synthetic heterovalent inhibitors targeting recognition E3 components of the N-end rule pathway

Min Jae Lee, Krishnendu Pal, Takafumi Tasaki et al. · Proceedings of the National Academy of Sciences · 2007 · 81 citations · Full text

, , +17

A Lipid-Modified Estrogen Derivative that Treats Breast Cancer Independent of Estrogen Receptor Expression through Simultaneous Induction of Autophagy and Apoptosis

Sutapa Sinha, Sayantani Roy, Bathula Surendar Reddy et al. · Molecular Cancer Research · 2011 · 45 citations · Full text

, , +17

Biology‐Oriented Synthesis of a Tetrahydroisoquinoline‐Based Compound Collection Targeting Microtubule Polymerization

Tobias J. Zimmermann, Sayantani Roy, Nancy E. Martinez et al. · ChemBioChem · 2013 · 39 citations

, , +15

17β-Estradiol-Linked Nitro-<scp>l</scp>-arginine as Simultaneous Inducer of Apoptosis in Melanoma and Tumor-Angiogenic Vascular Endothelial Cells

Sayantani Roy, Bathula Surendar Reddy, Godeshala Sudhakar et al. · Molecular Pharmaceutics · 2011 · 19 citations

, , +16

Total Synthesis of (−)‐Doliculide, Structure–Activity Relationship Studies and Its Binding to F‐Actin

Kiran Matcha, Ashoka V. R. Madduri, Sayantani Roy et al. · ChemBioChem · 2012 · 18 citations · Full text

, , +17

1–5 of 8